Best for
Mobile

Assura Plc (AGR) is a leading reit-healthcare facilities business based in the UK. It opened the day at 72.6p after a previous close of 71.9p. During the day the price has varied from a low of 71.1p to a high of 72.7p. The latest price was 72.3p (25 minute delay). Assura is listed on the London Stock Exchange (LSE) and employs 73 staff. All prices are listed in pence sterling.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Since the stock market crash in March caused by coronavirus, Assura's share price has had significant negative movement.
Its last market close was 75p, which is 7.64% down on its pre-crash value of 81.2p and 20.58% up on the lowest point reached during the March crash when the shares fell as low as 62.2p.
If you had bought £1,000 worth of Assura shares at the start of February 2020, those shares would have been worth £914.73 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £968.99.
Open | 72.6p |
---|---|
High | 72.7p |
Low | 71.1p |
Close | 72.3p |
Previous close | 71.9p |
Change | 0.4p |
Change % | 0.556% |
Volume | 5,141,819 |
52-week range | 60.5166p - 85.6185p |
---|---|
50-day moving average | 74.8912p |
200-day moving average | 77.8578p |
Wall St. target price | 61.33p |
PE ratio | 22.6176 |
Dividend yield | 0.03p (3.69%) |
Earnings per share (TTM) | 3.4p |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of 72.3p
1 week (2021-01-15) | -4.49% |
---|---|
1 month (2020-12-23) | -5.12% |
3 months (2020-10-23) | -7.43% |
6 months (2020-07-23) | -8.48% |
1 year (2020-01-23) | -6.47% |
---|---|
2 years (2019-01-23) | 31.22% |
3 years (2018-01-23) | 17.18% |
5 years (2016-01-22) | 37.19% |
Valuing Assura stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Assura's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Assura's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Assura shares trade at around 23x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Assura's P/E ratio is best considered in relation to those of others within the reit-healthcare facilities industry or those of similar companies.
Assura's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £94.6 million.
The EBITDA is a measure of a Assura's overall financial performance and is widely used to measure a its profitability.
To put Assura's EBITDA into context you can compare it against that of similar companies.
Revenue TTM | £115.5 million |
---|---|
Operating margin TTM | 81.82% |
Gross profit TTM | £103.7 million |
Return on assets TTM | 2.51% |
Return on equity TTM | 6.2% |
Profit margin | 74.72% |
Book value | 0.562p |
Market capitalisation | £2 billion |
TTM: trailing 12 months
Dividend payout ratio: 7067.5% of net profits
Recently Assura has paid out, on average, around 7067.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.69% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Assura shareholders could enjoy a 3.69% return on their shares, in the form of dividend payments. In Assura's case, that would currently equate to about 0.03p per share.
Assura's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 10 December 2020 (the "ex-dividend date").
Assura's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Over the last 12 months, Assura's shares have ranged in value from as little as 60.5166p up to 85.6185p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Assura's is 0.0475. This would suggest that Assura's shares are less volatile than average (for this exchange).
To put Assura's beta into context you can compare it against those of similar companies.
Subscribe to trending stock alerts for a chance to win
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.